Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1426 AL 1440

The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: From pathophysiology to therapeutic approaches

Liu W, Li Y, Zhao T, Gong M, Wang X, Zhang Y, Xu L, Li W, Li Y, Jia J.

Prog Neurobiol. 2023 Dec;231:102534. doi: 10.1016/j.pneurobio.2023.102534. Epub 2023 Sep 30.

Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update

Huang LK, Kuan YC, Lin HW, Hu CJ.

J Biomed Sci. 2023 Oct 2;30(1):83. doi: 10.1186/s12929-023-00976-6.

Neuroproteomic mapping of kinases and their substrates downstream of acetylcholine: finding and implications

Yamahashi Y, Tsuboi D, Funahashi Y, Kaibuchi K.

Expert Rev Proteomics. 2023 Jul-Dec;20(11):291-298. doi: 10.1080/14789450.2023.2265067. Epub 2023 Oct 30.

Friends and Foes in Alzheimer's Disease

Pauwels EKJ, Boer GJ.

Med Princ Pract. 2023;32(6):313-322. doi: 10.1159/000534400. Epub 2023 Oct 3.

Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)

Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q, Yang L, Xu P, Jiang X.

Int J Mol Med. 2023 Nov;52(5):111. doi: 10.3892/ijmm.2023.5314. Epub 2023 Oct 6.

Advances in the discovery of heterocyclic-based drugs against Alzheimer's disease

Sánchez JD, Alcántara AR, González JF, Sánchez-Montero JM.

Expert Opin Drug Discov. 2023 Jul-Dec;18(12):1413-1428. doi: 10.1080/17460441.2023.2264766. Epub 2023 Nov 1.

Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer's Disease

Jain U, Johari S, Srivastava P.

Mol Neurobiol. 2024 Apr;61(4):1969-1989. doi: 10.1007/s12035-023-03671-7. Epub 2023 Oct 13.

Donanemab: Not two without a third

Kurkinen M.

Adv Clin Exp Med. 2023 Oct;32(10):1085-1087. doi: 10.17219/acem/172673.

Memantine: Updating a rare success story in pro-cognitive therapeutics

Karimi Tari P, Parsons CG, Collingridge GL, Rammes G.

Neuropharmacology. 2024 Feb 15;244:109737. doi: 10.1016/j.neuropharm.2023.109737. Epub 2023 Oct 11.

Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus

Veselov IM, Vinogradova DV, Maltsev AV, Shevtsov PN, Spirkova EA, Bachurin SO, Shevtsova EF.

Int J Mol Sci. 2023 Sep 22;24(19):14450. doi: 10.3390/ijms241914450.

Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis

Fedele E.

Int J Mol Sci. 2023 Sep 24;24(19):14499. doi: 10.3390/ijms241914499.

Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges

He C, Gu J, Wang D, Wang K, Wang Y, You Q, Wang L.

Eur J Med Chem. 2023 Dec 5;261:115859. doi: 10.1016/j.ejmech.2023.115859. Epub 2023 Oct 6.

Landscape of Phase II Trials in Alzheimer's Disease

Lee A, Shan D, Castle D, Rajji TK, Ma C.

J Alzheimers Dis. 2023;96(2):745-757. doi: 10.3233/JAD-230660.

The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review

Arjmandi-Rad S, Vestergaard Nieland JD, Goozee KG, Vaseghi S.

Neurol Sci. 2024 Feb;45(2):417-430. doi: 10.1007/s10072-023-07114-y. Epub 2023 Oct 16.

Understanding Alzheimer's Disease and its Metal Chelation Therapeutics: A Narrative Review

Thakur R, Karwasra R, Umar T.

Curr Pharm Des. 2023;29(30):2377-2386. doi: 10.2174/0113816128263992231012113847.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias